Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Insulin detemir

Insulin detemir

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Insulin detemir

32 trials tracked of Insulin detemir: 27 in phase 3 or 4 and 1 with published results. The most-cited published study has 48 citations.

32Trials tracked
27Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 13 Phase 3 14 Phase 2 2 Other / NA 3
  1. Phase 3 Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes Completed · 48 cited
  2. Phase 4 Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes Completed
  3. Phase 4 Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen Completed
  4. Phase 4 Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea Completed
  5. Phase 4 Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Completed
  6. Phase 4 Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. Completed
Show 26 more trials
  1. Phase 4 Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes Completed
  2. Phase 4 Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes Completed
  3. Phase 4 Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial Completed
  4. Phase 4 Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily Completed
  5. Phase 4 A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs) Completed
  6. Phase 4 A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM) Completed
  7. Phase 4 Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment Completed
  8. Phase 4 Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs Completed
  9. Phase 3 Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes Completed
  10. Phase 3 Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689 Completed
  11. Phase 3 Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes Completed
  12. Phase 3 Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes Completed
  13. Phase 3 Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes Completed
  14. Phase 3 Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes Completed
  15. Phase 3 A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus Completed
  16. Phase 3 Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes Completed
  17. Phase 3 The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes Completed
  18. Phase 3 Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes Completed
  19. Phase 3 A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus Completed
  20. Phase 3 Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes Completed
  21. Phase 3 Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes Completed
  22. Phase 2 Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes Completed
  23. Phase 2 Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) Completed
  24. N/A Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes Completed
  25. N/A Observational Study to Evaluate the Safety of Levemir® in Diabetes Completed
  26. N/A Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake Completed

Showing the 32 most-cited and recently-updated of 32 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.